Literature DB >> 20441166

Stereoselective conjugation, transport and bioactivity of s- and R-hesperetin enantiomers in vitro.

Walter Brand1, Jia Shao, Elisabeth F Hoek-van den Hil, Kathelijn N van Elk, Bert Spenkelink, Laura H J de Haan, Maarit J Rein, Fabiola Dionisi, Gary Williamson, Peter J van Bladeren, Ivonne M C M Rietjens.   

Abstract

The flavanone hesperetin ((+/-)-4'-methoxy-3',5,7-trihydroxyflavanone) is the aglycone of hesperidin, which is the major flavonoid present in sweet oranges. Hesperetin contains a chiral C-atom and so can exist as an S- and R-enantiomer, however, in nature 2S-hesperidin and its S-hesperetin aglycone are predominant. The present study reports a chiral HPLC method to separate S- and R-hesperetin on an analytical and semipreparative scale. This allowed characterization of the stereoselective differences in metabolism and transport in the intestine and activity in a selected bioassay of the separated hesperetin enantiomers in in vitro model systems: (1) with human small intestinal fractions containing UDP-glucuronosyl transferases (UGTs) or sulfotransferases (SULTs); (2) with Caco-2 cell monolayers as a model for the intestinal transport barrier; (3) with mouse Hepa-1c1c7 cells transfected with human EpRE-controlled luciferase to test induction of EpRE-mediated gene expression. The results obtained indicate some significant differences in the metabolism and transport characteristics and bioactivity between S- and R-hesperetin, however, these differences are relatively small. This indicates that for these end points, including intestinal metabolism and transport and EpRE-mediated gene induction, experiments performed with racemic hesperetin may adequately reflect what can be expected for the naturally occurring S-enantiomer. This is an important finding since at present hesperetin is only commercially available as a racemic mixture, while it exists in nature mainly as an S-enantiomer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20441166     DOI: 10.1021/jf1008617

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  8 in total

Review 1.  Bioavailability of bioactive food compounds: a challenging journey to bioefficacy.

Authors:  Maarit J Rein; Mathieu Renouf; Cristina Cruz-Hernandez; Lucas Actis-Goretta; Sagar K Thakkar; Marcia da Silva Pinto
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

2.  Hesperidin Bioavailability Is Increased by the Presence of 2S-Diastereoisomer and Micronization-A Randomized, Crossover and Double-Blind Clinical Trial.

Authors:  Anna Crescenti; Antoni Caimari; Juan María Alcaide-Hidalgo; Roger Mariné-Casadó; Rosa M Valls; Judit Companys; Patricia Salamanca; Lorena Calderón-Pérez; Laura Pla-Pagà; Anna Pedret; Antoni Delpino-Rius; Pol Herrero; Iris Samarra; Lluís Arola; Rosa Solà; Josep M Del Bas
Journal:  Nutrients       Date:  2022-06-15       Impact factor: 6.706

3.  Hesperetin impairs glucose uptake and inhibits proliferation of breast cancer cells.

Authors:  Yong Yang; Joy Wolfram; Kathryn Boom; Xiaohong Fang; Haifa Shen; Mauro Ferrari
Journal:  Cell Biochem Funct       Date:  2012-10-08       Impact factor: 3.685

Review 4.  Effect of Hesperidin on Cardiovascular Disease Risk Factors: The Role of Intestinal Microbiota on Hesperidin Bioavailability.

Authors:  Anna Mas-Capdevila; Joan Teichenne; Cristina Domenech-Coca; Antoni Caimari; Josep M Del Bas; Xavier Escoté; Anna Crescenti
Journal:  Nutrients       Date:  2020-05-20       Impact factor: 5.717

5.  Effects of 8 Weeks of 2S-Hesperidin Supplementation on Performance in Amateur Cyclists.

Authors:  Francisco Javier Martínez-Noguera; Cristian Marín-Pagán; Jorge Carlos-Vivas; Pedro E Alcaraz
Journal:  Nutrients       Date:  2020-12-21       Impact factor: 5.717

6.  Hesperidin prevents retinal and plasma abnormalities in streptozotocin-induced diabetic rats.

Authors:  Xiupu Shi; Sha Liao; Huijuan Mi; Changrun Guo; Dongli Qi; Fei Li; Chunfeng Zhang; Zhonglin Yang
Journal:  Molecules       Date:  2012-11-01       Impact factor: 4.411

7.  Metabolomics Elucidates Dose-Dependent Molecular Beneficial Effects of Hesperidin Supplementation in Rats Fed an Obesogenic Diet.

Authors:  Maria Guirro; Andreu Gual-Grau; Albert Gibert-Ramos; Juan Maria Alcaide-Hidalgo; Núria Canela; Lluís Arola; Jordi Mayneris-Perxachs
Journal:  Antioxidants (Basel)       Date:  2020-01-16

Review 8.  Chiral Flavonoids as Antitumor Agents.

Authors:  Cláudia Pinto; Honorina Cidade; Madalena Pinto; Maria Elizabeth Tiritan
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.